Epigral Ltd Share Price

Chemicals - Speciality - LargeNSE
₹1,120.50
+38.30+3.54% (1D)
As on 20 Aug 2026 at 15:59
As of 20 Aug 2026 at 15:59, Epigral Ltd is trading at ₹1,120.50. The 52-week range stands at ₹807.00–₹1,911.60, with a market cap of ₹4.83 thousand crore. At a P/E of 17.79 and a dividend yield of 0.45%, it is a small-cap stock in the Chemicals sector.

EPIGRAL Price Chart

Market Cap
₹4.83K Cr
PE Ratio
17.79
ROCE
14.73%

Epigral Ltd Performance

Epigral Ltd Fundamentals

Market Cap₹4.83K Cr
ROE14.99%
P/E Ratio (TTM)17.79
EPS (TTM)₹63.00
P/B Ratio2.18
Dividend Yield0.45%
Industry P/E103.49
Book Value₹514.93
Debt to Equity0.26
Face Value₹10

Epigral Ltd Shareholding Pattern

Promoter68.8%
Foreign Institutions1%
Mutual Funds5.5%
Domestic Institutions0%
Public24.6%

Epigral Ltd Financial Statements

No data for this view.

Epigral Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
SRF Ltd
₹2,570.50
-8.10(-0.31%)
76,196.02,355.0 - 3,210.0
Linde India Ltd
₹6,694.42
-8.08(-0.12%)
57,092.85,673.0 - 8,049.0
Godrej Industries Ltd
₹1,226.50
8.50(+0.70%)
41,314.8744.2 - 1,443.0
Himadri Speciality Chemical Ltd
₹703.65
-46.60(-6.21%)
35,504.4418.5 - 819.5
Deepak Nitrite Ltd
₹1,749.95
-18.35(-1.04%)
23,868.11,280.0 - 1,904.4

About Epigral

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products. The Company was incorporated as a subsidiary of Meghmani Organics Limited. Name of the Company was changed to Epigral Limited dated August 4, 2023. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021. The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21. The Company is now among the leading players in India's chlor alkali industry. In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited. The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant). The timely commissioning of the plants represented the faith of the management in the long-term potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The Company further commissioned the capacity expansion of Caustic Soda manufacturing facility to 400 KTPA by adding 106 KTPA facility, along with expansion of 36 MW Captive Power Plant on 30th September, 2022. It commissioned Epichlorohydrin (ECH) manufacturing facility with a capacity of 50,000 TPA on 1st June, 2022, which is used in varied applications, such as Epoxy Resin, Water Treatment Chemicals, Textiles, Pharmaceuticals, Paper Reinforcement, Synthetic Glycerine, etc. It commissioned CPVC Resin manufacturing facility with a capacity of 30,000 TPA capacity on 18th July, 2022. In 2024-25, Company commissioned additional capacity of 45,000 TPA of CPVC Resin facility in April, 2024, reaching total capacity of CPVC Resin to 75,000 TPA. It also forward integrated and commissioned CPVC Compound facility of 35,000 TPA in June, 2024. Company has announced expansion of additional 75,000 TPA capacity of CPVC Resin plant at its Dahej facility in Gujarat. With this expansion, Company's total CPVC resin capacity reaches a remarkable 1,50,000 TPA in FY25. Company has commissioned India's First Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on 24th March, 2025. The Company has steadily expanded its Chlor-Alkali production from 1,67,000 TPA in 2015 to 4,21,000 TPA, in the Derivatives and Specialties portfolio in FY 2025-26.

Parent Organisation
Founded2007
Managing DirectorMaulik Jayantibhai Patel
NSE SymbolEPIGRAL

Epigral Ltd Resistance and Support levels

R31,121.27R21,104.80R11,094.63S11,061.70S21,051.53S31,035.071,120.50

Epigral Ltd Technicals

Current Price
₹1,120.50 ₹38.30 (+3.54%)
Bearish
4
Bullish
8
  • 20 Day1.5%
  • 50 Day1.2%
  • 100 Day0.4%
  • 200 Day8.2%

Epigral Ltd Latest News

View More
27 JUL 2026 | Monday
Epigral plans to set up new plant at Dahej
22 JUL 2026 | Wednesday
Epigral to convene board meeting
04 JUN 2026 | Thursday
Epigral rises after Crisil Ratings affirms ratings at 'AA/A1+' with 'stable' outlook
15 MAY 2026 | Friday
Epigral AGM scheduled
04 MAY 2026 | Monday
Epigral soars after Q4 PAT jumps over two-fold to Rs 82 cr
02 MAY 2026 | Saturday
Board of Epigral recommends final dividend
27 APR 2026 | Monday
Epigral to announce Quarterly Result & final dividend

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Epigral Ltd is ₹1,120.50 as of 20 Aug 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now